YPSN Stock Overview
Develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Ypsomed Holding AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 358.00 |
| 52 Week High | CHF 439.00 |
| 52 Week Low | CHF 273.50 |
| Beta | 0.97 |
| 11 Month Change | -12.90% |
| 3 Month Change | -12.25% |
| 1 Year Change | 27.18% |
| 33 Year Change | 96.27% |
| 5 Year Change | 162.85% |
| Change since IPO | 383.78% |
Recent News & Updates
Recent updates
Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Interim Results
Nov 17
Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects
Aug 13There Are Reasons To Feel Uneasy About Ypsomed Holding's (VTX:YPSN) Returns On Capital
Jul 31If EPS Growth Is Important To You, Ypsomed Holding (VTX:YPSN) Presents An Opportunity
Jul 03Here's Why Ypsomed Holding AG's (VTX:YPSN) CEO May Deserve A Raise
Jun 19Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF395?
Jun 10Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Full-Year Results
May 25Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects
May 08Investors Could Be Concerned With Ypsomed Holding's (VTX:YPSN) Returns On Capital
Apr 07Is There Now An Opportunity In Ypsomed Holding AG (VTX:YPSN)?
Mar 09Here's Why We Think Ypsomed Holding (VTX:YPSN) Might Deserve Your Attention Today
Feb 07We Think Ypsomed Holding (VTX:YPSN) Can Stay On Top Of Its Debt
Jan 23Ypsomed Holding AG's (VTX:YPSN) Popularity With Investors Is Clear
Jan 08Here's What's Concerning About Ypsomed Holding's (VTX:YPSN) Returns On Capital
Dec 23Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF298?
Dec 05Do Ypsomed Holding's (VTX:YPSN) Earnings Warrant Your Attention?
Sep 28Ypsomed Holding (VTX:YPSN) Seems To Use Debt Quite Sensibly
Sep 10Ypsomed Holding (VTX:YPSN) May Have Issues Allocating Its Capital
Aug 23Should You Think About Buying Ypsomed Holding AG (VTX:YPSN) Now?
Aug 08Should You Be Adding Ypsomed Holding (VTX:YPSN) To Your Watchlist Today?
Jun 13Ypsomed Holding (VTX:YPSN) Seems To Use Debt Quite Sensibly
May 28What Does Ypsomed Holding AG's (VTX:YPSN) Share Price Indicate?
May 06Ypsomed Holding (VTX:YPSN) Could Be Struggling To Allocate Capital
Apr 21At CHF187, Is It Time To Put Ypsomed Holding AG (VTX:YPSN) On Your Watch List?
Feb 01These 4 Measures Indicate That Ypsomed Holding (VTX:YPSN) Is Using Debt Reasonably Well
Jan 17Is Now The Time To Put Ypsomed Holding (VTX:YPSN) On Your Watchlist?
Dec 27Investors Shouldn't Be Too Comfortable With Ypsomed Holding's (VTX:YPSN) Robust Earnings
Nov 24What Is Ypsomed Holding AG's (VTX:YPSN) Share Price Doing?
Oct 19Why Ypsomed Holding AG (VTX:YPSN) Could Be Worth Watching
Jul 14Here's What's Concerning About Ypsomed Holding's (VTX:YPSN) Returns On Capital
Jun 20Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF161?
Feb 28Shareholder Returns
| YPSN | CH Medical Equipment | CH Market | |
|---|---|---|---|
| 7D | -13.3% | -5.9% | -1.8% |
| 1Y | 27.2% | 13.1% | 6.1% |
Return vs Industry: YPSN exceeded the Swiss Medical Equipment industry which returned 13.1% over the past year.
Return vs Market: YPSN exceeded the Swiss Market which returned 6.1% over the past year.
Price Volatility
| YPSN volatility | |
|---|---|
| YPSN Average Weekly Movement | 4.6% |
| Medical Equipment Industry Average Movement | 3.9% |
| Market Average Movement | 3.3% |
| 10% most volatile stocks in CH Market | 6.5% |
| 10% least volatile stocks in CH Market | 1.6% |
Stable Share Price: YPSN's share price has been volatile over the past 3 months compared to the Swiss market.
Volatility Over Time: YPSN's weekly volatility (5%) has been stable over the past year, but is still higher than 75% of Swiss stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 2,296 | Simon Michel | www.ypsomed.com |
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices.
Ypsomed Holding AG Fundamentals Summary
| YPSN fundamental statistics | |
|---|---|
| Market cap | CHF 4.89b |
| Earnings (TTM) | CHF 74.39m |
| Revenue (TTM) | CHF 617.07m |
65.7x
P/E Ratio7.9x
P/S RatioIs YPSN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| YPSN income statement (TTM) | |
|---|---|
| Revenue | CHF 617.07m |
| Cost of Revenue | CHF 398.41m |
| Gross Profit | CHF 218.66m |
| Other Expenses | CHF 144.28m |
| Earnings | CHF 74.39m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.45 |
| Gross Margin | 35.44% |
| Net Profit Margin | 12.05% |
| Debt/Equity Ratio | 0% |
How did YPSN perform over the long term?
See historical performance and comparison